THE CHEMOURS COMPANY
Ownership & governance
Executives 5Directors 10Avg age 59Avg tenure 2.5y
DD
Denise Dignam
Chief Executive Officer
Age 60Since 2024-02-27Profile →
+14
Executives5
Board of directors10
MC
Mary Cranston→
Chairman
Age 78Since 2025-09-01
SK
Sean Keohane→
Director/Board Member
Age 59Since 2017-12-31
EK
Erin Kane→
Director/Board Member
Age 49Since 2019-06-17
DD
Denise Dignam→
Director/Board Member
Age 60Since 2024-03-21
AC
Alister Cowan→
Director/Board Member
Age 61Since 2023-11-21
PF
Pamela Fletcher→
Director/Board Member
Age 60Since 2024-02-29
LS
Livingston Satterthwaite→
Director/Board Member
Age 65Since 2024-06-11
JK
Joseph Kava→
Director/Board Member
Age 58Since 2025-01-02
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BlackRock Advisors LLC | 14.05 % | 21,133,807 |
| Vanguard Portfolio Management LLC | 6.866 % | 10,325,341 |
| Vanguard Capital Management LLC | 4.505 % | 6,773,917 |
| STATE STREET CORPORATION | 4.072 % | 6,123,088 |
| Ameriprise Financial Services LLC | 3.217 % | 4,837,803 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Denise Dignam | Chief Executive Officer | 2024-02-27 | - |
| Mary Cranston | Chairman | 2025-09-01 | - |
| Shane Hostetter | Director of Finance/CFO | 2024-06-30 | - |
| Alister Cowan | Director/Board Member | 2023-11-21 | - |
| Courtney Mather | Director/Board Member | 2025-04-21 | - |
| Denise Dignam | Director/Board Member | 2024-03-21 | - |
| Erin Kane | Director/Board Member | 2019-06-17 | - |
| Joseph Kava | Director/Board Member | 2025-01-02 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| The Chemours Company FC LLC | Chemicals: Specialty |
| The Chemours Company FC LLC | Chemicals: Specialty |
| The Chemours India Pvt Ltd. | Chemicals: Specialty |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus holdMean target 16.9Range 14–24Analysts 10
14Mean 16.924
- Buy 2
- Hold 8
Broker actions40 of 191
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Mizuho | Downgrade | Neutral | 15 | 2026-10-14 |
| Barclays | Initiated | Equal-Weight | 16 | 2026-10-13 |
| UBS | Maintained | Neutral | 16 | 2026-10-05 |
| Mizuho | Maintained | Outperform | 18 | 2026-09-30 |
| JP Morgan | Maintained | Neutral | 15 | 2026-08-13 |
| BMO Capital | Maintained | Outperform | 18 | 2026-08-13 |
| UBS | Downgrade | Neutral | 18 | 2026-08-10 |
| RBC Capital | Maintained | Outperform | 22 | 2026-08-06 |
| Truist Securities | Maintained | Buy | 24 | 2026-08-06 |
| Mizuho | Maintained | Outperform | 25 | 2026-07-01 |
| JP Morgan | Maintained | Neutral | 22 | 2026-05-21 |
| Morgan Stanley | Maintained | Equal-Weight | 21 | 2026-05-11 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.